Citations

Mayo Clinic

Showing 10 of 108551 citations.

Validation of GPT‐4 for clinical event classification: A comparative analysis with ICD codes and human reviewers
Wang, Yichen , Huang, Yuting , Nimma, Induja R., Pang, Songhan, Pang, Maoyin , Cui, Tao, Kumbhari, Vivek , Huang, Yuting , Wang, Yichen , Cui, Tao

Journal of Gastroenterology and Hepatology | April 17, 2024 | Volume: 39 | Issue: 8 | Pages: 1535-1543

10.1111/jgh.16561 | PMID 38627920 Get It

AbstractBackground and AimEffective clinical event classification is essential for clinical research and quality improvement. The validation of artificial intelligence (AI) models like Generative Pre‐trained Transformer 4 (GPT‐4) for this task and comparison with conventional methods remains unexplored.MethodsWe evaluated the performance of the GPT‐4 model for classifying gastrointestinal (GI) bleeding episodes from 200 medical discharge summaries and compared the results with human review and an International Classification of Diseases (ICD) code‐based system. The analysis included accuracy, sensitivity, and specificity evaluation, using ground truth determined by physician reviewers.ResultsGPT‐4 exhibited an accuracy of 94.4% in identifying GI bleeding occurrences, outperforming ICD codes (accuracy 63.5%, P < 0.001). GPT‐4's accuracy was either slightly lower or statistically similar to individual human reviewers (Reviewer 1: 98.5%, P < 0.001; Reviewer 2: 90.8%, P = 0.170). For location classification, GPT‐4 achieved accuracies of 81.7% and 83.5% for confirmed and probable GI bleeding locations, respectively, with figures that were either slightly lower or comparable with those of human reviewers. GPT‐4 was highly efficient, analyzing the dataset in 12.7 min at a cost of 21.2 USD, whereas human reviewers required 8–9 h each.ConclusionOur study indicates GPT‐4 offers a reliable, cost‐efficient, and faster alternative to current clinical event classification methods, outperforming the conventional ICD coding system and performing comparably to individual expert human reviewers. Its implementation could facilitate more accurate and granular clinical research and quality audits. Future research should explore scalability, prompt and model tuning, and ethical implications of high‐performance AI models in clinical data processing.
Normal transferrin glycosylation does not rule out severe ALG1 deficiency
Bosnyák, Inez, Sadek, Mustafa , Ranatunga, Wasantha , Morava, Éva , Morava, Eva , Kozicz, Tamás

JIMD Reports | April 17, 2024 | Volume: 65 | Issue: 3 | Pages: 135-143

10.1002/jmd2.12415 | PMID 38736633 Get It

AbstractALG1‐CDG is a rare, clinically variable metabolic disease, caused by the defect of adding the first mannose (Man) to N‐acetylglucosamine (GlcNAc2)‐pyrophosphate (PP)‐dolichol to the growing oligosaccharide chain, resulting in impaired N‐glycosylation of proteins. N‐glycosylation has a key role in functionality, stability, and half‐life of most proteins. Therefore, congenital defects of glycosylation typically are multisystem disorders. Here we report a 3‐year‐old patient with severe neurological, cardiovascular, respiratory, musculoskeletal and gastrointestinal symptoms. ALG1‐CDG was suggested based on exome sequencing and Western blot analysis. Despite her severe clinical manifestations and genetic diagnosis, serum transferrin glycoform analysis was normal. Western blot analysis of highly glycosylated proteins in fibroblasts revealed decreased intercellular adhesion molecule 1 (ICAM1), but normal lysosomal associated membrane protein 1 and 2 (LAMP1 and LAMP2) expression levels. Glycoproteomics in fibroblasts showed the presence of the abnormal tetrasacharide. Reviewing the literature, we found 86 reported ALG1‐CDG patients, but only one with normal transferrin analysis. Based on our results we would like to highlight the importance of multiple approaches in diagnosing ALG1‐CDG, as normal serum transferrin glycosylation or other biomarkers with normal expression levels can occur.
COVID-19 and renal allograft rejection: insight from controlled and non-controlled studies
Soliman, Karim , Salas, Maria Aurora Posadas , Uehara, Genta, Vaishnav, Sakshi, Cheungpasitporn, Wisit , Casey, Michael J. , Cheungpasitporn, Wisit , Soliman, Karim M , Daoud, Ahmed

Renal Failure | April 17, 2024 | Volume: 46 | Issue: 1 | Pages: No page available

10.1080/0886022x.2024.2336126 | PMID 38627208 Get It

Assessment of management reasoning: Design considerations drawn from analysis of simulated outpatient encounters
Cook, David A. , Durning, Steven J. , Stephenson, Christopher R. , Gruppen, Larry D. , Lineberry, Matt , Lineberry, Matthew

Medical Teacher | April 17, 2024 | Volume: 47 | Issue: 2 | Pages: 218-232

10.1080/0142159x.2024.2337251 | PMID 38627020 Get It

Machine learning in cardiac stress test interpretation: a systematic review
Barzilai, Dor Hadida , Cohen-Shelly, Michal , Sorin, Vera , Zimlichman, Eyal , Massalha, Eias , Allison, Thomas G. , Klang, Eyal , Hadida Barzilai, Dor

European Heart Journal - Digital Health | April 17, 2024 | Volume: 5 | Issue: 4 | Pages: 401-408

10.1093/ehjdh/ztae027 | PMID 39081945 Get It

Abstract Coronary artery disease (CAD) is a leading health challenge worldwide. Exercise stress testing is a foundational non-invasive diagnostic tool. Nonetheless, its variable accuracy prompts the exploration of more reliable methods. Recent advancements in machine learning (ML), including deep learning and natural language processing, have shown potential in refining the interpretation of stress testing data. Adhering to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, we conducted a systematic review of ML applications in stress electrocardiogram (ECG) and stress echocardiography for CAD prognosis. Medical Literature Analysis and Retrieval System Online, Web of Science, and the Cochrane Library were used as databases. We analysed the ML models, outcomes, and performance metrics. Overall, seven relevant studies were identified. Machine-learning applications in stress ECGs resulted in sensitivity and specificity improvements. Some models achieved rates of above 96% in both metrics and reduced false positives by up to 21%. In stress echocardiography, ML models demonstrated an increase in diagnostic precision. Some models achieved specificity and sensitivity rates of up to 92.7 and 84.4%, respectively. Natural language processing applications enabled the categorization of stress echocardiography reports, with accuracy rates nearing 98%. Limitations include a small, retrospective study pool and the exclusion of nuclear stress testing, due to its well-documented status. This review indicates the potential of artificial intelligence applications in refining CAD stress testing assessment. Further development for real-world use is warranted.
Prostate Cancer, Version 3.2024
Schaeffer, Edward M. , Srinivas, Sandy, An, Yi , Bitting, Rhonda L. , Chapin, Brian F. , D’Amico, Anthony V. , Desai, Neil , Dorff, Tanya B. , Eastham, James A., Farrington, Thomas A., Gupta, Shilpa , Guzzo, Thomas, Karnes, R. Jeffrey , Kuettel, Michael, McKay, Rana R. , Morgan, Todd M. , Pow‐Sang, Julio M. , Reiter, Robert E. , Roach, Mack , Rosenfeld, Stan, Shabsigh, Ahmad , Valicenti, Richard K., Wong, J.K. , Snedeker, Jenna, Freedman-Cass, Deborah A., Morgan, Todd M , Robin, Tyler P. , Adra, Nabil , Cheng, Heather H. , Gao, Xin Yuan , Ippolito, Joseph E. , Lang, Joshua M. , Lotan, Tamara Levin , Spratt, Daniel E. , Szmulewitz, Russell Z , Teply, Benjamin A. , Tward, Jonathan D.

Journal of the National Comprehensive Cancer Network | April 16, 2024 | Volume: 22 | Issue: 3 | Pages: 140-150

10.6004/jnccn.2024.0019 | PMID 38626801 Get It

The NCCN Guidelines for Prostate Cancer include recommendations for staging and risk assessment after a prostate cancer diagnosis and for the care of patients with localized, regional, recurrent, and metastatic disease. These NCCN Guidelines Insights summarize the panel's discussions for the 2024 update to the guidelines with regard to initial risk stratification, initial management of very-low-risk disease, and the treatment of nonmetastatic recurrence.
Twin Pregnancy Complicated by Gestational Diabetes Mellitus: Maternal and Neonatal Outcomes
Das, Devika , Hegazi, Moustafa , Takawy, Marina, Pone, Karina, Vella, Adrian , Egan, Aoife M. , Takawy, Marina , Christie, Hannah E. , Pone, Karina A, Vella, Adrian , Egan, A M , Das, Devika , Takawy, Marina

Journal of the Endocrine Society | April 16, 2024 | Volume: 8 | Issue: 6 | Pages: No page available

10.1210/jendso/bvae075 | PMID 38698871 Get It

Abstract Context The risk of gestational diabetes mellitus (GDM) in twin pregnancies is more than double that of singleton pregnancies. Although twin pregnancies present unique challenges for fetal growth and prenatal management, the approach to GDM diagnosis and treatment is the same regardless of plurality. Data on pregnancy outcomes for individuals with GDM and a twin pregnancy are limited and conflicting. Objective To describe the maternal characteristics associated with GDM in twin pregnancies and to assess the associated pregnancy outcomes compared to twin pregnancies unaffected by GDM. Methods A retrospective cohort study was conducted at Mayo Clinic, Rochester, Minnesota, USA, and included predominantly Causasian women aged 18 to 45 years who received prenatal care for a twin pregnancy from 2017-2022. Maternal characteristics and a broad spectrum of pregnancy outcomes were evaluated. Universal GDM screening involved a 50 g oral glucose challenge test +/− a 100 g oral glucose tolerance test. Results GDM was diagnosed in 23% pregnancies (n = 104/452). Compared to those without, women with GDM had known risk factors including a higher prepregnancy body mass index (31.1vs 26.3 kg/m2; P &lt; .01) and a prior history of GDM (21.7 vs 5.9%; P &lt; .01). There were no differences in maternal pregnancy complications or neonatal outcomes between groups. Attendance at postpartum glucose testing among women with GDM was poor at 27.9% (29/104). Conclusion These data suggest that women with twin pregnancies share a similar GDM risk profile to those with singleton pregnancies and provide reassuring evidence that current management for GDM twin pregnancies produces similar outcomes to twin pregnancies without GDM.
Genital Surgery Outcomes Using an Individualized Algorithm for Hormone Management in Transfeminine Individuals
Herndon, Justine , Davidge‐Pitts, Caroline , Imhof, Nicole, González, César A. , Carlson, Sara, Will, Marissa, Martinez‐Jorge, Jorys, Fahradyan, Vahe , Tamire, Lily, Lin, Anna L., Nippoldt, Todd B., Chang, Alice Y. , Gupta, Nidhi , Davidge-Pitts, Caroline , Gonzalez, Cesar , Martinez-Jorge, Jorys, Fahradyan, Vahe , Lin, Anna, Chang, Alice Y , Carlson, Sara, Lin, Anna

The Journal of Clinical Endocrinology & Metabolism | April 16, 2024 | Volume: 109 | Issue: 11 | Pages: 2774-2783

10.1210/clinem/dgae269 | PMID 38629916 Get It

Abstract Context Transgender and gender diverse (TGD) individuals have greater access to genital surgery (GS) with improved insurance coverage and access to trained surgeons and interdisciplinary gender-affirming providers. Objective To determine perioperative medical and behavioral health outcomes in transfeminine (TF) individuals undergoing GS, with use of a specific gender-affirming hormone therapy (GAHT) algorithm based on individualized risk factor assessment. Methods In this retrospective observational cohort study, we collected preoperative and postoperative data from 183 TF individuals at a single tertiary referral center from 2017 to 2022, grouping patients by those who continued estradiol (Group 1) vs those who had temporarily discontinued estradiol for 2 to 6 weeks preoperatively (Group 2). Data included clinical and biochemical assessment, GAHT regimens, validated behavioral health measures, and postoperative complications. Main outcomes included venous thromboembolism (VTE) incidence, non-VTE postoperative complication incidence, and change in behavioral health assessments. Results The majority of individuals continued estradiol perioperatively (Group 1; 138 [75.4%]). Individuals who temporarily held estradiol preoperatively (Group 2; 45 [24.6%]) were statistically older (P &lt; .01), had higher incidence of cardiometabolic comorbidities (P &lt; .01), and higher Caprini scores (P &lt; .01). Group 1 was statistically more likely to use oral estradiol (P &lt; .01). One episode (0.05%) of VTE occurred (Group 1). There was no significant difference in postoperative complications or behavioral health measures between groups. Conclusion An individualized algorithm for preoperative hormone management for TF GS resulted in perioperative continuation of GAHT for the majority of individuals without significantly increasing the risk for postoperative surgical complications, while maintaining stable behavioral health measures perioperatively.
Enhancing outcomes in deep brain stimulation: a comparative study of direct targeting using 7T versus 3T MRI
Middlebrooks, Erik H. , Tipton, Philip W. , Patel, Vishal , Zhou, Xiangzhi , Tao, Shengzhen , Westerhold, Erin , Straub, Sina , Uitti, Ryan J. , Quiñones‐Hinojosa, Alfredo , Middlebrooks, Erik H , Tipton, Philip W , Straub, Sina , Greco, Elena, Okromelidze, Lela , Wszołek, Zbigniew K. , Sandhu, Sukhwinder J.S. , Grewal, Sanjeet S.

Journal of Neurosurgery | April 16, 2024 | Volume: 141 | Issue: 1 | Pages: 252-259

10.3171/2023.12.jns232473 | PMID 38394660 Get It

OBJECTIVE The aim of this study was to compare outcomes of direct targeting in deep brain stimulation (DBS) for essential tremor using 7T MRI versus 3T MRI. The authors hypothesized that 7T MRI direct targeting would be noninferior to 3T MRI in early tremor outcomes. METHODS A retrospective study was conducted on patients undergoing unilateral thalamic DBS for essential tremor between 2021 and 2023. Two matched cohorts were assessed, one using 7T MRI and the other using 3T MRI for surgical planning. The primary endpoint was the percentage improvement in the Fahn-Tolosa-Marin Tremor Rating Scale (TRS) scores. Additionally, the authors assessed optimized programming settings and variance in electrode position on postoperative imaging. Demographic and clinical data were compared using the nonparametric Mann-Whitney U-test. The squared Euclidean distance of each contact from the group mean centroid was calculated and averaged across the entire cohort to provide the variance (i.e., the mean squared distance) of electrode contact position. RESULTS A total of 34 patients were analyzed, with 17 in each cohort. There were no significant differences in demographic information or mean surgical dates between the groups. There were no differences in intraoperative target repositioning or adverse events. The 7T group had a significantly greater TRS improvement than the 3T group (64.9% ± 11.4% vs 50.9% ± 16.4%, p = 0.004). Patients in the 7T cohort also had a lower mean stimulation current compared with those in the 3T cohort (2.0 ± 0.8 mA vs 2.7 ± 0.9 mA, p = 0.01). Image evaluation revealed that although the mean electrode position was comparable between 7T and 3T, the 7T electrode positioning was more clustered, indicating a lower variance in the final electrode location. The mean Euclidean distance between the individual electrode tips and the group centroid was significantly less at 7T than at 3T (1.82 ± 0.68 mm vs 2.75 ± 0.81 mm, p = 0.001). CONCLUSIONS Despite concerns for increased artifacts and distortions at 7T, the authors show that these effects can be mitigated with an appropriate workflow, leading to improved surgical outcomes with direct targeting using 7T MRI. Their results suggest similar accuracy but greater precision in targeting with 7T MRI compared with 3T MRI, resulting in lower stimulation currents and improved tremor reduction. Future studies are needed to assess outcomes related to 7T MRI in targeting other subcortical structures.
Cervical spondylotic myelopathy and driving abilities: defining the prevalence and long-term postoperative outcomes using the Quality Outcomes Database
Agarwal, Nitin , Johnson, Sarah E. , Bydon, Mohamad , Bisson, Erica F. , Chan, Andrew K. , Shabani, Saman , Michalopoulos, Giorgos D. , Lu, Daniel C. , Wang, Michael Y. , Haid, Regis W., Knightly, John J. , Sherrod, Brandon A. , Gottfried, Oren N., Shaffrey, Christopher I. , Virk, Michael S. , Hussain, Ibrahim , Glassman, Steven D. , Shaffrey, Mark E., Foley, Kevin T. , Pennicooke, Brenton , Coric, Domagoj , Slotkin, Jonathan R., Upadhyaya, Cheerag D., Potts, Eric A. , Tumialán, Luis M. , Chou, Dean , Fu, Kai-Ming, Asher, Anthony L. , Mummaneni, Praveen V. , Michalopoulos, Giorgos , Letchuman, Vijay , Lavadi, Raj Swaroop , Goldberg, Jacob L. , Park, Paul

Journal of Neurosurgery: Spine | April 16, 2024 | Volume: 40 | Issue: 5 | Pages: 630-641

10.3171/2023.11.spine23738 | PMID 38364219 Get It

OBJECTIVE Cervical spondylotic myelopathy (CSM) can cause significant difficulty with driving and a subsequent reduction in an individual’s quality of life due to neurological deterioration. The positive impact of surgery on postoperative patient-reported driving capabilities has been seldom explored. METHODS The CSM module of the Quality Outcomes Database was utilized. Patient-reported driving ability was assessed via the driving section of the Neck Disability Index (NDI) questionnaire. This is an ordinal scale in which 0 represents the absence of symptoms while driving and 5 represents a complete inability to drive due to symptoms. Patients were considered to have an impairment in their driving ability if they reported an NDI driving score of 3 or higher (signifying impairment in driving duration due to symptoms). Multivariable logistic regression models were fitted to evaluate mediators of baseline impairment and improvement at 24 months after surgery, which was defined as an NDI driving score < 3. RESULTS A total of 1128 patients who underwent surgical intervention for CSM were included, of whom 354 (31.4%) had baseline driving impairment due to CSM. Moderate (OR 2.3) and severe (OR 6.3) neck pain, severe arm pain (OR 1.6), mild-moderate (OR 2.1) and severe (OR 2.5) impairment in hand/arm dexterity, severe impairment in leg use/walking (OR 1.9), and severe impairment of urinary function (OR 1.8) were associated with impaired driving ability at baseline. Of the 291 patients with baseline impairment and available 24-month follow-up data, 209 (71.8%) reported postoperative improvement in their driving ability. This improvement seemed to be mediated particularly through the achievement of the minimal clinically important difference (MCID) in neck pain and improvement in leg function/walking. Patients with improved driving at 24 months noted higher postoperative satisfaction (88.5% vs 62.2%, p < 0.01) and were more likely to achieve a clinically significant improvement in their quality of life (50.7% vs 37.8%, p < 0.01). CONCLUSIONS Nearly one-third of patients with CSM report impaired driving ability at presentation. Seventy-two percent of these patients reported improvements in their driving ability within 24 months of surgery. Surgical management of CSM can significantly improve patients’ driving abilities at 24 months and hence patients’ quality of life.